Alnylam Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ALNY and other ETFs, options, and stocks.

About ALNY

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the business of developing and commercializing novel therapeutics based on ribonucleic acid interference. 

CEO
Yvonne L. Greenstreet
CEOYvonne L. Greenstreet
Employees
2,230
Employees2,230
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2002
Founded2002
Employees
2,230
Employees2,230

ALNY Key Statistics

Market cap
59.63B
Market cap59.63B
Price-Earnings ratio
-188.85
Price-Earnings ratio-188.85
Dividend yield
Dividend yield
Average volume
1.23M
Average volume1.23M
High today
$466.24
High today$466.24
Low today
$454.55
Low today$454.55
Open price
$464.80
Open price$464.80
Volume
82.84K
Volume82.84K
52 Week high
$484.21
52 Week high$484.21
52 Week low
$205.87
52 Week low$205.87

ALNY News

Simply Wall St 2d
Assessing Alnylam After Stock Surges 100% on RNAi Momentum in 2025

If you own Alnylam Pharmaceuticals stock or are thinking about starting a position, you might be feeling a mix of excitement and caution right now. With shares...

Assessing Alnylam After Stock Surges 100% on RNAi Momentum in 2025
TipRanks 3d
Alnylam Pharma Executes Note Repurchase Transactions

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Seeking Alpha 3d
Pfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: Bloomberg

Healthcare Pfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: Bloomberg Sep. 12, 2025 8:55 AM ET Pfizer Inc. (PFE) Stock, ALNY Stock,...

Pfizer, Alnylam earn BridgeBio ire over sales tactics for amyloidosis drugs: Bloomberg

Analyst ratings

75%

of 32 ratings
Buy
75%
Hold
21.9%
Sell
3.1%

More ALNY News

Seeking Alpha 7d
Alnylam announces proposed offering of $500M convertible senior notes

Healthcare Alnylam announces proposed offering of $500M convertible senior notes Sep. 08, 2025 4:24 PM ET Alnylam Pharmaceuticals, Inc. (ALNY) Stock By: Nivedit...

Alnylam announces proposed offering of $500M convertible senior notes
TipRanks 7d
Alnylam announces $500M convertible senior notes offering

Alnylam (ALNY) Pharmaceuticals announced that it has commenced a private offering of $500M aggregate principal amount of convertible senior notes due 2028 to pe...

People also own

Based on the portfolios of people who own ALNY. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.